» Articles » PMID: 12212695

Influence of QRS Duration on the Prognostic Value of T Wave Alternans

Overview
Date 2002 Sep 6
PMID 12212695
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: T wave alternans (TWA) is a promising new noninvasive marker of arrhythmia vulnerability that quantifies beat-to-beat changes in ventricular repolarization. Secondary repolarization abnormalities are common in subjects with wide QRS complexes. However, the relationship between TWA and QRS prolongation has not been evaluated. The goal of this study was to determine if QRS prolongation influences the prevalence or prognostic value of TWA.

Methods And Results: The study consisted of 108 consecutive patients with coronary artery disease and left ventricular ejection fraction < or = 40% who were referred for electrophysiologic studies. Patients underwent TWA testing using bicycle ergometry in the absence of beta-blockers or antiarrhythmic drugs. The primary endpoint was the combined incidence of death, sustained ventricular arrhythmias, and appropriate implantable cardioverter defibrillator therapy. The prognostic value of TWA was assessed in the entire cohort and in two subgroups: QRS < 120 msec (normal, n = 62) and QRS > or = 120 msec (prolonged, n = 46). TWA (hazard ratio 2.2, P = 0.03) and QRS prolongation (hazard ratio 2.2, P = 0.01) were both significant and independent predictors of arrhythmic events. QRS prolongation had no effect on the prevalence of positive TWA tests (QRS < 120 msec: 48%, QRS > or = 120 msec: 50%, P = NS). TWA was a highly significant predictor of events in patients with a normal QRS (hazard ratio 5.8, P = 0.02). In contrast, TWA was not useful for risk stratification in subjects with QRS prolongation (hazard ratio 1.1, P = 0.8).

Conclusion: TWA is useful only for risk stratification in the absence of QRS prolongation. The presence of QRS prolongation and left ventricular ejection fraction < or = 40% may be sufficient evidence of an adverse prognosis that additional risk stratification is not useful or necessary.

Citing Articles

T-Wave Alternans in Nonpathological Preterm Infants.

Marcantoni I, Sbrollini A, Agostinelli G, Chiara Surace F, Colaneri M, Morettini M Ann Noninvasive Electrocardiol. 2020; 25(4):e12745.

PMID: 31986237 PMC: 7358874. DOI: 10.1111/anec.12745.


Reduced T wave alternans in heart failure responders to cardiac resynchronization therapy: Evidence of electrical remodeling.

Nayyar S, Suszko A, Porta-Sanchez A, Dalvi R, Chauhan V PLoS One. 2018; 13(6):e0199637.

PMID: 29953465 PMC: 6023131. DOI: 10.1371/journal.pone.0199637.


T-wave alternans and ST depression assessment identifies low risk individuals with ischemic cardiomyopathy in the absence of left ventricular hypertrophy.

Friedman D, Bender S, Markowitz S, Lerman B, Okin P Ann Noninvasive Electrocardiol. 2013; 18(4):359-68.

PMID: 23879276 PMC: 6932106. DOI: 10.1111/anec.12051.


Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure.

Nearing B, Wellenius G, Mittleman M, Josephson M, Burger A, Verrier R Circ Arrhythm Electrophysiol. 2011; 5(1):84-90.

PMID: 22157521 PMC: 3296063. DOI: 10.1161/CIRCEP.111.965434.


Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.

Verrier R, Klingenheben T, Malik M, El-Sherif N, Exner D, Hohnloser S J Am Coll Cardiol. 2011; 58(13):1309-24.

PMID: 21920259 PMC: 4111570. DOI: 10.1016/j.jacc.2011.06.029.